| 1 | RNA transcripts serve as a template for double-strand break repair in human cells | 11.0 | 13 | Citations (PDF) |
| 2 | APOBEC3 mutagenesis drives therapy resistance in breast cancer | 14.2 | 35 | Citations (PDF) |
| 3 | Auto-segmentation of neck nodal metastases using self-distilled masked image transformer on longitudinal MR images. 2024, 1, ubae004 | | 3 | Citations (PDF) |
| 4 | Multi-scale geometric network analysis identifies melanoma immunotherapy response gene modules | 2.7 | 5 | Citations (PDF) |
| 5 | A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms | 4.2 | 21 | Citations (PDF) |
| 6 | Genotype-Directed Synthetic Cytotoxicity of ATR Inhibition with Radiotherapy | 4.5 | 9 | Citations (PDF) |
| 7 | Large-scale copy number alterations are enriched for synthetic viability in BRCA1/BRCA2 tumors | 5.9 | 5 | Citations (PDF) |
| 8 | Micronuclear collapse from oxidative damage | 26.5 | 77 | Citations (PDF) |
| 9 | RAD52 resolves transcription-replication conflicts to mitigate R-loop induced genome instability | 11.0 | 22 | Citations (PDF) |
| 10 | Tumor Hypoxia on 18F-fluoromisonidazole Positron Emission Tomography and Distant Metastasis From Head and Neck Squamous Cell Carcinoma | 5.2 | 9 | Citations (PDF) |
| 11 | Neoantigen immunogenicity landscapes and evolution of tumor ecosystems during immunotherapy with nivolumab | 25.8 | 43 | Citations (PDF) |
| 12 | Impact of immune infiltration signatures on prognosis in endometrial carcinoma is dependent on the underlying molecular subtype | 2.3 | 17 | Citations (PDF) |
| 13 | Immune selection determines tumor antigenicity and influences response to checkpoint inhibitors | 14.2 | 82 | Citations (PDF) |
| 14 | Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers | 31.8 | 50 | Citations (PDF) |
| 15 | Nivolumab plus ipilimumab in advanced salivary gland cancer: a phase 2 trial | 25.8 | 62 | Citations (PDF) |
| 16 | An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals | 3.3 | 6 | Citations (PDF) |
| 17 | Abstract PO-025: The effect of tissue of origin on oncogenesis in HPV-related malignancies: Comparative analysis of molecular and immune signatures in HPV-positive head and neck cancer and cervical cancer | 4.5 | 0 | Citations (PDF) |
| 18 | An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals. | 2.3 | 2 | Citations (PDF) |
| 19 | Most large structural variants in cancer genomes can be detected without long reads | 14.2 | 44 | Citations (PDF) |
| 20 | Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus–Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy | 11.1 | 95 | Citations (PDF) |
| 21 | Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology | 1.1 | 10 | Citations (PDF) |
| 22 | Effects of Tumor Mutational Burden and Gene Alterations Associated with Radiation Response on Outcomes of Postoperative Radiation Therapy in Non-Small Cell Lung Cancer | 1.4 | 23 | Citations (PDF) |
| 23 | Cancer-Causative Mutations Occurring in Early Embryogenesis | 6.8 | 32 | Citations (PDF) |
| 24 | Colorectal Cancer Develops Inherent Radiosensitivity That Can Be Predicted Using Patient-Derived Organoids | 4.2 | 44 | Citations (PDF) |
| 25 | A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer | 3.0 | 30 | Citations (PDF) |
| 26 | Prognostic impact of extranodal extension (ENE) in surgically managed treatment-naive HPV-positive oropharyngeal squamous cell carcinoma with nodal metastasis | 3.8 | 31 | Citations (PDF) |
| 27 | Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity | 14.2 | 72 | Citations (PDF) |
| 28 | Transcriptional and functional analyses of neoantigen-specific CD4 T cells during a profound response to anti-PD-L1 in metastatic Merkel cell carcinoma | 5.3 | 17 | Citations (PDF) |
| 29 | Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy. | 3.3 | 67 | Citations (PDF) |
| 30 | The head and neck cancer genome in the era of immunotherapy | 1.5 | 17 | Citations (PDF) |
| 31 | Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma. | 16.5 | 385 | Citations (PDF) |
| 32 | The association between tumor mutational burden and prognosis is dependent on treatment context | 14.2 | 232 | Citations (PDF) |
| 33 | Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial | 3.3 | 151 | Citations (PDF) |
| 34 | Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors | 11.0 | 403 | Citations (PDF) |
| 35 | Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy | 1.4 | 22 | Citations (PDF) |
| 36 | Any day, split halfway: Flexibility in scheduling high-dose cisplatin—A large retrospective review from a high-volume cancer center | 2.8 | 3 | Citations (PDF) |
| 37 | TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer | 4.7 | 29 | Citations (PDF) |
| 38 | Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development | 4.7 | 9 | Citations (PDF) |
| 39 | Reproducibility of radiomic features using network analysis and its application in Wasserstein k-means clustering | 0.9 | 4 | Citations (PDF) |
| 40 | Synthetic Lethality in Cancer Therapeutics: The Next Generation | 6.8 | 208 | Citations (PDF) |
| 41 | Molecular characterization of high-grade serous ovarian cancers occurring in younger and older women | 2.3 | 12 | Citations (PDF) |
| 42 | Tumor Immunity and Immunotherapy for HPV-Related Cancers | 6.8 | 200 | Citations (PDF) |
| 43 | Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy | 5.2 | 70 | Citations (PDF) |
| 44 | Intensity-modulated radiation therapy and doxorubicin in thyroid cancer: A prospective phase 2 trial | 2.7 | 31 | Citations (PDF) |
| 45 | The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers | 1.4 | 5 | Citations (PDF) |
| 46 | The Genetic Evolution of Treatment-Resistant Cutaneous, Acral, and Uveal Melanomas | 4.5 | 13 | Citations (PDF) |
| 47 | Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis | 6.8 | 289 | Citations (PDF) |
| 48 | Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination | 4.7 | 30 | Citations (PDF) |
| 49 | Current considerations for radiotherapy in HPV-associated head and neck cancer | 1.2 | 7 | Citations (PDF) |
| 50 | Improved prediction of immune checkpoint blockade efficacy across multiple cancer types | 21.4 | 253 | Citations (PDF) |
| 51 | Patterns of Radiotherapy Use and Outcomes in Head and Neck Soft-Tissue Sarcoma in a National Cohort | 0.8 | 5 | Citations (PDF) |
| 52 | Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer | 2.7 | 67 | Citations (PDF) |
| 53 | Microenvironmental Heterogeneity Among Triple-Negative Breast Cancer Subtypes and the Promise of Precision Medicine. | 3.3 | 2 | Citations (PDF) |
| 54 | A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell Carcinoma | 1.4 | 67 | Citations (PDF) |
| 55 | Platinum-based regimens versus cetuximab in definitive chemoradiation for human papillomavirus-unrelated head and neck cancer | 2.8 | 20 | Citations (PDF) |
| 56 | Distinct Classes of Complex Structural Variation Uncovered across Thousands of Cancer Genome GraphsCell, 2020, 183, 197-210.e32 | 23.8 | 267 | Citations (PDF) |
| 57 | Protein-Protein interactions uncover candidate ‘core genes’ within omnigenic disease networks | 2.2 | 32 | Citations (PDF) |
| 58 | Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy | 15.0 | 199 | Citations (PDF) |
| 59 | Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyngeal carcinoma | 1.4 | 17 | Citations (PDF) |
| 60 | Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignancies | 0.7 | 3 | Citations (PDF) |
| 61 | Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers | 1.5 | 28 | Citations (PDF) |
| 62 | Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma | 1.5 | 49 | Citations (PDF) |
| 63 | The Immune Microenvironment and Neoantigen Landscape of Aggressive Salivary Gland Carcinomas Differ by Subtype | 4.5 | 114 | Citations (PDF) |
| 64 | Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies | 2.7 | 53 | Citations (PDF) |
| 65 | Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection | 4.5 | 227 | Citations (PDF) |
| 66 | Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base. | 0.1 | 29 | Citations (PDF) |
| 67 | ERCC2 Helicase Domain Mutations Confer Nucleotide Excision Repair Deficiency and Drive Cisplatin Sensitivity in Muscle-Invasive Bladder Cancer | 4.5 | 162 | Citations (PDF) |
| 68 | Timing of surgery and adjuvant radiation therapy for sinonasal malignancies: Effect of surgical approach | 1.4 | 17 | Citations (PDF) |
| 69 | Human papillomavirus 16 promotes microhomology-mediated end-joining | 5.3 | 88 | Citations (PDF) |
| 70 | Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy | 4.3 | 51 | Citations (PDF) |
| 71 | Big Data in Cancer Research: Real-World Resources for Precision Oncology to Improve Cancer Care Delivery | 2.3 | 29 | Citations (PDF) |
| 72 | The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists | 1.4 | 91 | Citations (PDF) |
| 73 | Association of a Pathway-Specific Genetic Risk Score With Risk of Radiation-Associated Contralateral Breast Cancer | 5.2 | 7 | Citations (PDF) |
| 74 | The Landscape of Somatic Genetic Alterations in Breast Cancers from CHEK2 Germline Mutation Carriers. | 2.3 | 36 | Citations (PDF) |
| 75 | Immunogenic neoantigens derived from gene fusions stimulate T cell responses | 25.8 | 382 | Citations (PDF) |
| 76 | Current Treatment Landscape of Nasopharyngeal Carcinoma and Potential Trials Evaluating the Value of Immunotherapy. | 3.3 | 71 | Citations (PDF) |
| 77 | A competing risk nomogram to predict severe late toxicity after modern re-irradiation for squamous carcinoma of the head and neck | 1.5 | 42 | Citations (PDF) |
| 78 | Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy | 25.8 | 313 | Citations (PDF) |
| 79 | Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy | 19.8 | 237 | Citations (PDF) |
| 80 | Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression | 2.3 | 97 | Citations (PDF) |
| 81 | Transcriptomic Profiling of the Tumor Microenvironment Reveals Distinct Subgroups of Clear Cell Renal Cell Cancer: Data from a Randomized Phase III Trial Free | 6.8 | 226 | Citations (PDF) |
| 82 | Tumor mutational load predicts survival after immunotherapy across multiple cancer types | 14.2 | 3,685 | Citations (PDF) |
| 83 | Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature | 1.4 | 31 | Citations (PDF) |
| 84 | Trends and Disparities of Proton Therapy Use among Patients with Head and Neck Cancer: Analysis from the National Cancer Database (2005-14). | 0.1 | 13 | Citations (PDF) |
| 85 | The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers | 3.3 | 122 | Citations (PDF) |
| 86 | Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery | 0.8 | 21 | Citations (PDF) |
| 87 | Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas. | 3.3 | 176 | Citations (PDF) |
| 88 | Head and neck cancers associated with exposure to the September 11, 2001 World Trade Center terrorist attacks | 2.8 | 7 | Citations (PDF) |
| 89 | Volume, Dose, and Fractionation Considerations for IMRT-based Reirradiation in Head and Neck Cancer: A Multi-institution Analysis. | 1.4 | 88 | Citations (PDF) |
| 90 | Merkel Cell Carcinoma Patients Presenting Without a Primary Lesion Have Elevated Markers of Immunity, Higher Tumor Mutation Burden, and Improved Survival Free | 4.5 | 71 | Citations (PDF) |
| 91 | A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer | 1.4 | 136 | Citations (PDF) |
| 92 | Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative. | 1.4 | 161 | Citations (PDF) |
| 93 | The DNA damage response in immunotherapy and radiation | 1.1 | 28 | Citations (PDF) |
| 94 | Image-based Data Mining to Probe Dosimetric Correlates of Radiation-induced Trismus | 1.4 | 48 | Citations (PDF) |
| 95 | Proton Therapy for Head and Neck Cancer | 3.1 | 62 | Citations (PDF) |
| 96 | The therapeutic significance of mutational signatures from DNA repair deficiency in cancer | 11.0 | 191 | Citations (PDF) |
| 97 | Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes | 28.7 | 281 | Citations (PDF) |
| 98 | Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease | 3.0 | 33 | Citations (PDF) |
| 99 | Proton Radiotherapy for Recurrent or Metastatic Head and Neck Cancers with Palliative Quad Shot. | 0.1 | 11 | Citations (PDF) |
| 100 | Internal and external generalizability of temporal dose–response relationships for xerostomia following IMRT for head and neck cancer | 1.5 | 9 | Citations (PDF) |
| 101 | The role of parotid gland irradiation in the development of severe hyposalivation (xerostomia) after intensity-modulated radiation therapy for head and neck cancer: Temporal patterns, risk factors, and testing the QUANTEC guidelines | 1.2 | 31 | Citations (PDF) |
| 102 | Transcriptional Mechanisms of Resistance to Anti–PD-1 Therapy | 4.5 | 78 | Citations (PDF) |
| 103 | Multiparametric Imaging of Tumor Hypoxia and Perfusion with 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer | 4.0 | 46 | Citations (PDF) |
| 104 | The Landscape of Somatic Genetic Alterations in Metaplastic Breast Carcinomas | 4.5 | 157 | Citations (PDF) |
| 105 | A magnetic resonance imaging-based approach to quantify radiation-induced normal tissue injuries applied to trismus in head and neck cancer | 1.0 | 31 | Citations (PDF) |
| 106 | Proton therapy for head and neck cancer: expanding the therapeutic window | 14.6 | 134 | Citations (PDF) |
| 107 | Patterns of Treatment Failure and Postrecurrence Outcomes Among Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma After Chemoradiotherapy Using Modern Radiation Techniques | 11.1 | 243 | Citations (PDF) |
| 108 | Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers | 4.5 | 171 | Citations (PDF) |
| 109 | Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer | 3.2 | 57 | Citations (PDF) |
| 110 | Compromised BRCA1–PALB2 interaction is associated with breast cancer risk | 5.2 | 85 | Citations (PDF) |
| 111 | The toxicity and efficacy of concomitant chemoradiotherapy in patients aged 70 years and older with oropharyngeal carcinoma in the intensity-modulated radiotherapy era | 2.7 | 24 | Citations (PDF) |
| 112 | Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma | 2.6 | 65 | Citations (PDF) |
| 113 | Multi-dimensional genomic analysis of myoepithelial carcinoma identifies prevalent oncogenic gene fusions | 11.0 | 106 | Citations (PDF) |
| 114 | Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes | 11.0 | 225 | Citations (PDF) |
| 115 | Tumor and Microenvironment Evolution during Immunotherapy with NivolumabCell, 2017, 171, 934-949.e16 | 23.8 | 2,227 | Citations (PDF) |
| 116 | Association of Number of Dissected Lymph Nodes With Survival in Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma Patients Undergoing Primary Surgery: A Population-Based Analysis | 2.7 | 20 | Citations (PDF) |
| 117 | Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer | 31.8 | 1,136 | Citations (PDF) |
| 118 | A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy | 31.8 | 675 | Citations (PDF) |
| 119 | Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer | 3.7 | 40 | Citations (PDF) |
| 120 | Sparing of high retropharyngeal nodal basins in patients with unilateral oropharyngeal carcinoma treated with intensity modulated radiation therapy | 1.8 | 26 | Citations (PDF) |
| 121 | The Molecular Landscape of Recurrent and Metastatic Head and Neck Cancers: Insights From a Precision Oncology Sequencing Platform | 11.1 | 225 | Citations (PDF) |
| 122 | PARP Inhibitor Activity Correlates with SLFN11 Expression and Demonstrates Synergy with Temozolomide in Small Cell Lung Cancer | 4.5 | 350 | Citations (PDF) |
| 123 | Patterns of nodal failure after intensity modulated radiotherapy for nasopharyngeal carcinoma | 0.8 | 22 | Citations (PDF) |
| 124 | Patterns of failure in head and neck cancer patients treated with intensity modulated radiation therapy: editorial response | 1.0 | 2 | Citations (PDF) |
| 125 | Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma | 2.1 | 19 | Citations (PDF) |
| 126 | The head and neck cancer immune landscape and its immunotherapeutic implications | 3.7 | 731 | Citations (PDF) |
| 127 | Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience | 0.8 | 20 | Citations (PDF) |
| 128 | Patterns of regional and distant metastasis in esthesioneuroblastoma | 0.8 | 68 | Citations (PDF) |
| 129 | Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck | 1.1 | 60 | Citations (PDF) |
| 130 | Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response | 1.4 | 35 | Citations (PDF) |
| 131 | The role of neoantigens in response to immune checkpoint blockade. | 2.0 | 180 | Citations (PDF) |
| 132 | Postoperative PET/CT and target delineation before adjuvant radiotherapy in patients with oral cavity squamous cell carcinoma | 1.4 | 20 | Citations (PDF) |
| 133 | Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy | 14.2 | 145 | Citations (PDF) |
| 134 | Cervical nodal level V can safely be omitted in the treatment of locally advanced oropharyngeal squamous cell carcinoma with definitive IMRT | 1.5 | 15 | Citations (PDF) |
| 135 | Impact of Flap Reconstruction on Radiotoxicity After Salvage Surgery and Reirradiation for Recurrent Head and Neck Cancer | 1.7 | 13 | Citations (PDF) |
| 136 | Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma. | 1.4 | 149 | Citations (PDF) |
| 137 | Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review | 1.4 | 15 | Citations (PDF) |
| 138 | Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study | 14.6 | 728 | Citations (PDF) |
| 139 | Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma | 1.5 | 52 | Citations (PDF) |
| 140 | Dose-volume factors correlating with trismus following chemoradiation for head and neck cancer | 1.4 | 45 | Citations (PDF) |
| 141 | Proton Radiation Therapy for Local Control in a Case of Osteosarcoma of the Neck. | 0.1 | 2 | Citations (PDF) |
| 142 | Sparing Bilateral Neck Level IB in Oropharyngeal Carcinoma and Xerostomia Outcomes | 1.1 | 37 | Citations (PDF) |
| 143 | Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers | 1.4 | 8 | Citations (PDF) |
| 144 | Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma | 1.5 | 63 | Citations (PDF) |
| 145 | Palliative head and neck radiotherapy with the RTOG 8502 regimen for incurable primary or metastatic cancers | 1.5 | 85 | Citations (PDF) |
| 146 | Definitive chemoradiation for primary oral cavity carcinoma: A single institution experience | 1.5 | 40 | Citations (PDF) |
| 147 | A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy | 2.7 | 129 | Citations (PDF) |
| 148 | The Effect of Adjuvant Trastuzumab on Locoregional Recurrence of Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Treated with Mastectomy | 1.7 | 32 | Citations (PDF) |
| 149 | Radiation Therapy in the Treatment of Minor Salivary Gland Tumors | 1.1 | 23 | Citations (PDF) |
| 150 | Image-guided Radiation Therapy for Liver Tumors | 1.1 | 7 | Citations (PDF) |
| 151 | Patterns of failure after salvage re-irradiation for recurrent head and neck cancer: implications for field design and consolidation therapy | 0.4 | 3 | Citations (PDF) |
| 152 | A nomogram to predict loco-regional control after re-irradiation for head and neck cancer | 1.5 | 87 | Citations (PDF) |
| 153 | Unraveling the molecular genetics of head and neck cancer through genome-wide approaches | 4.3 | 91 | Citations (PDF) |
| 154 | The relative prognostic utility of standardized uptake value, gross tumor volume, and metabolic tumor volume in oropharyngeal cancer patients treated with platinum based concurrent chemoradiation with a pre-treatment [F] fluorodeoxyglucose positron emission tomography scan | 1.5 | 39 | Citations (PDF) |
| 155 | Patients with low lying lymph nodes are at high risk for distant metastasis in oropharyngeal cancer | 1.5 | 21 | Citations (PDF) |
| 156 | Efficacy of concurrent cetuximab vs. 5-fluorouracil/carboplatin or high-dose cisplatin with intensity-modulated radiation therapy (IMRT) for locally-advanced head and neck cancer (LAHNSCC) | 1.5 | 53 | Citations (PDF) |
| 157 | Treatment of maxillary sinus cancer in the modern era: one institution’s experience | 0.4 | 2 | Citations (PDF) |
| 158 | Temporary organ displacement coupled with image-guided, intensity-modulated radiotherapy for paraspinal tumors | 2.1 | 11 | Citations (PDF) |
| 159 | Distant metastasis is a critical mode of failure for patients with localized major salivary gland tumors treated with surgery and radiation | 0.4 | 6 | Citations (PDF) |
| 160 | Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma | 2.1 | 8 | Citations (PDF) |
| 161 | Long-term regional control in the observed neck following definitive chemoradiation for node-positive oropharyngeal squamous cell cancer | 2.8 | 36 | Citations (PDF) |
| 162 | Time Course and Predictors for Cancer-Related Fatigue in a Series of Oropharyngeal Cancer Patients Treated with Chemoradiation Therapy | 2.4 | 27 | Citations (PDF) |
| 163 | Interactive semiautomatic contour delineation using statistical conditional random fields framework | 2.1 | 17 | Citations (PDF) |
| 164 | Pretreatment Endorectal Coil Magnetic Resonance Imaging Findings Predict Biochemical Tumor Control in Prostate Cancer Patients Treated With Combination Brachytherapy and External-Beam Radiotherapy | 1.4 | 38 | Citations (PDF) |
| 165 | Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy† | 2.7 | 60 | Citations (PDF) |
| 166 | Intensity-modulated radiation therapy for nasopharyngeal carcinoma: a review | 0.4 | 61 | Citations (PDF) |
| 167 | Revisiting Low-Dose Total Skin Electron Beam Therapy in Mycosis Fungoides | 1.4 | 96 | Citations (PDF) |
| 168 | The Stanford University Experience With Conventional-Dose, Total Skin Electron-Beam Therapy in the Treatment of Generalized Patch or Plaque (T2) and Tumor (T3) Mycosis Fungoides | 1.5 | 116 | Citations (PDF) |
| 169 | Use of MV and kV imager correlation for maintaining continuous real-time 3D internal marker tracking during beam interruptions | 2.0 | 14 | Citations (PDF) |
| 170 | Predicting respiratory tumor motion with multi-dimensional adaptive filters and support vector regression* | 2.0 | 101 | Citations (PDF) |
| 171 | Image-Guided Radiotherapy in Near Real Time With Intensity-Modulated Radiotherapy Megavoltage Treatment Beam Imaging | 1.4 | 28 | Citations (PDF) |
| 172 | A fiducial detection algorithm for real-time image guided IMRT based on simultaneous MV and kV imaging | 2.1 | 50 | Citations (PDF) |
| 173 | TH-C-AUD C-07: Prediction of Fiducial Motion in Respiratory Tumors for Image-Guided Radiotherapy | 2.1 | 1 | Citations (PDF) |
| 174 | TH-C-AUD C-06: Nearly Real-Time Tumor-Position Monitoring During Arc Therapy with Combined MV and KV Imaging | 2.1 | 0 | Citations (PDF) |
| 175 | WE-C-351-06: Tracking Multiple Moving Fiducials During Treatment Based On Simultaneous Onboard KV and Treatment MV Imaging | 2.1 | 0 | Citations (PDF) |
| 176 | A generalized approach to automated NMR peak list editing: application to reduced dimensionality triple resonance spectra | 1.6 | 39 | Citations (PDF) |
| 177 | 10.1016/b978-1-4557-4696-5.00118-4 | 0.0 | 0 | Citations (PDF) |
| 178 | Mitochondrial DNA copy number variation across human cancers. | 1.0 | 504 | Citations (PDF) |
| 179 | Proton Therapy for Paranasal Sinus Cancer: Clinical Outcomes and Patterns of Failure | 1.4 | 1 | Citations (PDF) |
| 180 | OA07.02 Tumor Burden Metrics at Oligoprogression and Survival After SBRT in NSCLC: An Analysis of the Randomized Phase II CURB Trial | 3.1 | 1 | Citations (PDF) |
| 181 | Optimal post-treatment surveillance strategy for human papillomavirus-positive oropharyngeal cancer. | 5.3 | 0 | Citations (PDF) |
| 182 | Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer | 15.0 | 9 | Citations (PDF) |
| 183 | Genomic Enrichment and Functional Impact of TP53 and CYLD Alterations in Recurrent and Metastatic HPV-Associated Head and Neck Cancer Available to Purchase | 4.5 | 1 | Citations (PDF) |
| 184 | Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial. | 25.8 | 14 | Citations (PDF) |
| 185 | Abstract 2615: Diffusion kurtosis imaging to predict tumor hypoxia and recurrence in HPV-associated oropharyngeal cancer. | 4.2 | 0 | Citations (PDF) |
| 186 | Abstract 5254: Copy number amplification of PSG is associated with poor survival in female lung adenocarcinoma patients | 4.2 | 0 | Citations (PDF) |
| 187 | Proton versus photon therapy for oropharyngeal cancer. | 45.9 | 1 | Citations (PDF) |
| 188 | Nonoperative Management of Locally Advanced Resectable Cutaneous Squamous Cell Cancer of the Head and Neck with PD-1 Blockade. | 4.5 | 0 | Citations (PDF) |
| 189 | Beyond auto-segmentation: the case for planning and dosimetry AI in head and neck radiation oncology. | 4.3 | 0 | Citations (PDF) |
| 190 | Beyond Tolerability: Putting Efficacy at the Center of Radiation Therapy-Drug Dose Optimization. | 1.4 | 0 | Citations (PDF) |
| 191 | Do not try this at home: patterns and outcomes of radiation dose de-escalation in p16-positive oropharyngeal carcinoma. | 1.7 | 0 | Citations (PDF) |
